Docusign Inc. $DOCU Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. lessened its holdings in shares of Docusign Inc. (NASDAQ:DOCU) by 21.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 762,634 shares of the company’s stock after selling 212,543 shares during the quarter. Pacer Advisors Inc.’s holdings in Docusign were worth $52,164,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the business. Kera Capital Partners Inc. increased its position in Docusign by 347.8% during the 4th quarter. Kera Capital Partners Inc. now owns 16,556 shares of the company’s stock valued at $1,132,000 after buying an additional 12,859 shares in the last quarter. Corient Private Wealth LLC boosted its holdings in Docusign by 256.7% in the fourth quarter. Corient Private Wealth LLC now owns 102,998 shares of the company’s stock worth $7,045,000 after acquiring an additional 74,122 shares in the last quarter. Alberta Investment Management Corp boosted its holdings in Docusign by 490.2% in the fourth quarter. Alberta Investment Management Corp now owns 72,000 shares of the company’s stock worth $4,925,000 after acquiring an additional 59,800 shares in the last quarter. Mercer Global Advisors Inc. ADV grew its stake in shares of Docusign by 32.9% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 65,594 shares of the company’s stock worth $4,487,000 after acquiring an additional 16,250 shares during the last quarter. Finally, Vident Advisory LLC grew its stake in shares of Docusign by 1.5% during the fourth quarter. Vident Advisory LLC now owns 46,373 shares of the company’s stock worth $3,172,000 after acquiring an additional 702 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

Docusign Stock Performance

Shares of NASDAQ DOCU opened at $43.47 on Friday. Docusign Inc. has a 12 month low of $40.16 and a 12 month high of $86.65. The company has a 50 day simple moving average of $47.17 and a two-hundred day simple moving average of $52.61. The stock has a market cap of $8.30 billion, a price-to-earnings ratio of 28.23, a PEG ratio of 1.32 and a beta of 0.92.

Docusign (NASDAQ:DOCU) last released its quarterly earnings data on Thursday, June 4th. The company reported $1.09 EPS for the quarter, beating the consensus estimate of $0.99 by $0.10. Docusign had a net margin of 9.59% and a return on equity of 17.48%. The business had revenue of $830.24 million for the quarter, compared to the consensus estimate of $824.71 million. During the same period in the prior year, the firm earned $0.90 EPS. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. Analysts forecast that Docusign Inc. will post 1.97 EPS for the current year.

Docusign announced that its board has approved a stock buyback program on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 21% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s management believes its stock is undervalued.

Insider Buying and Selling at Docusign

In other Docusign news, CRO Paula Hansen sold 6,000 shares of Docusign stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $46.84, for a total transaction of $281,040.00. Following the completion of the transaction, the executive owned 79,233 shares in the company, valued at approximately $3,711,273.72. This trade represents a 7.04% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mary Agnes Wilderotter sold 3,000 shares of the business’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $48.15, for a total value of $144,450.00. Following the completion of the transaction, the director directly owned 59,803 shares of the company’s stock, valued at approximately $2,879,514.45. This trade represents a 4.78% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 48,793 shares of company stock valued at $2,322,737 in the last three months. Company insiders own 0.59% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on DOCU shares. Weiss Ratings raised shares of Docusign from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, June 3rd. Royal Bank Of Canada dropped their target price on shares of Docusign from $70.00 to $55.00 and set a “sector perform” rating on the stock in a research report on Wednesday, March 18th. Needham & Company LLC restated a “hold” rating on shares of Docusign in a research note on Friday, June 5th. Morgan Stanley decreased their price target on shares of Docusign from $90.00 to $69.00 and set an “equal weight” rating for the company in a report on Wednesday, March 18th. Finally, BTIG Research lowered their price objective on shares of Docusign from $70.00 to $60.00 and set a “buy” rating for the company in a research note on Friday, June 5th. Three analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Docusign presently has a consensus rating of “Hold” and a consensus price target of $60.27.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.